90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
about
Arterial Therapies of Non-Colorectal Liver MetastasesEffects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsThe role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based reviewChemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.Radioembolization for primary and metastatic liver cancer.The role of (18)F-FDG positron emission tomography in the follow-up of liver tumors treated with (90)Yttrium radioembolization.Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases.Techniques of interventional tumor therapy.Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomesState of the art: radiolabeled microspheres treatment for liver malignancies.Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature.Evidence-based integration of selective internal radiation therapy into the management of breast cancer liver metastases.(90)Y-glass microspheres for hepatic neoplasia.The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.C-arm computed tomography compared with positron emission tomography/computed tomography for treatment planning before radioembolization.Impressive Response to Concomitant Platinum-based Chemotherapy and Yttrium-90 in a Patient with Heavily Pretreated Triple-negative Breast Cancer Widely Metastasized to the Liver.Standards of practice in transarterial radioembolization.Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.Intraarterial Liver-Directed Therapies: The Role of Interventional Oncology.Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.Radioembolisation with (90)Y-labelled resin microspheres in the treatment of liver metastasis from breast cancer.Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
P2860
Q26764990-627D0D23-01B8-4596-A874-C7B354DD691BQ26799046-B31DDDEE-5DB5-4A2E-8F4A-7B5EB9C08370Q26863629-F2CEA72A-1A65-409F-9909-954198FF00A7Q34330617-FB65F28E-E430-46B0-BCD0-DDCEA4F854ADQ35564038-CCB5C71E-3B5D-4656-A5B2-A3D9F5B14634Q35656582-0602275B-A04D-4129-B31D-B7E811D3BC6EQ35822196-3F12BA32-B25E-4774-A4C4-353E84AEC7FAQ36392298-2EE4CE7A-9C12-4CA2-BD9B-C44CF6FCF100Q36482781-5C9817E3-7033-4F33-8EAD-60B4AAF3848FQ37082835-D8860FF0-AB85-4BBC-A960-868881DB0E7AQ37496689-7DB6A8BE-D88C-44B9-8205-5830BFB47DAAQ37669068-04E9EC4A-06E5-4248-8A99-FF25757DE67AQ37693928-92BBCE84-1E7D-49C9-87E1-0A755D454E9CQ37876332-145A84E5-F700-43C2-BAD3-A25D688ABD94Q38192781-7352943C-8D5F-4631-A72B-32578CB2861FQ38283687-D3F799F8-8768-48B3-B40A-A95EA3373E40Q38465831-8ECD32A8-9898-4685-9DD6-F3FF774D3310Q39456177-B09FD009-9451-4E1D-8BA7-E3E3C9D650F8Q39935458-05123513-87AB-4B55-9749-B34906486C9AQ41531931-4E5C72D5-71DF-4277-AFB2-D7FD684C8806Q45128821-8484FA02-02D5-4C8F-ADE4-ABBAF709E0ACQ45168728-DECA689F-84BD-4B86-A2EC-00E59651C38CQ45207818-41844315-A193-43DE-9AE0-F1570113F369Q47101871-52AE9AE8-1064-414B-9833-5909E6DB5DBBQ50672514-D4934663-A1CC-4145-8DB0-189E2C792D70Q51322653-515572CC-0322-4D12-80F6-9702264B95E3Q58702255-F3FD36FA-C805-41BB-A743-EB84B0451B23
P2860
90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
90Y radioembolization of metas ...... y, imaging response, survival.
@en
90Y radioembolization of metas ...... y, imaging response, survival.
@nl
type
label
90Y radioembolization of metas ...... y, imaging response, survival.
@en
90Y radioembolization of metas ...... y, imaging response, survival.
@nl
prefLabel
90Y radioembolization of metas ...... y, imaging response, survival.
@en
90Y radioembolization of metas ...... y, imaging response, survival.
@nl
P2093
P1476
90Y radioembolization of metas ...... y, imaging response, survival.
@en
P2093
Affaan K Bangash
Bassel Atassi
Kent T Sato
Maurice Yu
Reed A Omary
Robert J Lewandowski
Robert K Ryu
Robert Mandal
Steven Newman
Thomas K Rhee
P304
P356
10.1016/J.JVIR.2007.02.019
P577
2007-05-01T00:00:00Z